Total Payments
$162,504
2024 Payments
$64,231
Companies
7
Transactions
105
Medicare Patients
1,394
Medicare Billing
$186,036
Payment Breakdown by Category
Consulting$126,164 (77.6%)
Travel$26,062 (16.0%)
Other$6,451 (4.0%)
Food & Beverage$3,746 (2.3%)
Education$80.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $126,164 | 26 | 77.6% |
| Travel and Lodging | $26,062 | 30 | 16.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,451 | 3 | 4.0% |
| Food and Beverage | $3,746 | 45 | 2.3% |
| Education | $80.81 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $131,162 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $30,505 | 13 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $325.17 | 4 | $0 (2024) |
| Travere Therapeutics, Inc. | $145.59 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $135.98 | 2 | $0 (2022) |
| GENZYME CORPORATION | $125.04 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $104.88 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64,231 | 33 | Alexion Pharmaceuticals, Inc. ($40,268) |
| 2023 | $70,571 | 31 | Alexion Pharmaceuticals, Inc. ($65,916) |
| 2022 | $10,223 | 19 | Alexion Pharmaceuticals, Inc. ($7,612) |
| 2021 | $900.00 | 2 | Alexion Pharmaceuticals, Inc. ($900.00) |
| 2020 | $5,725 | 3 | Alexion Pharmaceuticals, Inc. ($5,725) |
| 2019 | $10,557 | 14 | Alexion Pharmaceuticals, Inc. ($10,443) |
| 2018 | $117.33 | 1 | Alexion Pharmaceuticals, Inc. ($117.33) |
| 2017 | $180.81 | 2 | Alexion Pharmaceuticals, Inc. ($180.81) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $80.64 | General |
| Category: Rare Disease | ||||||
| 03/21/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $60.48 | General |
| Category: Rare Disease | ||||||
| 03/21/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $38.50 | General |
| Category: Rare Disease | ||||||
| 03/21/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: Rare Disease | ||||||
| 03/04/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $125.04 | General |
| Category: Hematology | ||||||
| 02/24/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Travel and Lodging | In-kind items and services | $400.02 | General |
| Category: Rare Disease | ||||||
| 02/24/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $39.10 | General |
| Category: Rare Disease | ||||||
| 02/24/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Rare Disease | ||||||
| 11/08/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $9,569.93 | General |
| Category: Rare Disease | ||||||
| 10/31/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Nephrology | ||||||
| 10/14/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $6,380.00 | General |
| Category: Rare Disease | ||||||
| 09/09/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $106.74 | General |
| Category: Nephrology | ||||||
| 09/08/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $127.68 | General |
| Category: Nephrology | ||||||
| 09/06/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $12,760.00 | General |
| Category: Rare Disease | ||||||
| 09/06/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $69.44 | General |
| Category: Rare Disease | ||||||
| 09/06/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $36.77 | General |
| Category: Rare Disease | ||||||
| 07/12/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $8,700.00 | General |
| Category: Rare Disease | ||||||
| 06/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $306.06 | General |
| Category: Rare Disease | ||||||
| 06/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $61.92 | General |
| Category: Rare Disease | ||||||
| 06/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $47.99 | General |
| Category: Rare Disease | ||||||
| 06/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $29.54 | General |
| Category: Rare Disease | ||||||
| 06/25/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $451.25 | General |
| Category: Rare Disease | ||||||
| 06/25/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $278.55 | General |
| Category: Rare Disease | ||||||
| 06/24/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $273.86 | General |
| Category: Rare Disease | ||||||
| 06/24/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $116.73 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 269 | 411 | $187,286 | $34,730 |
| 2022 | 7 | 260 | 434 | $124,344 | $33,419 |
| 2021 | 9 | 380 | 692 | $279,721 | $53,508 |
| 2020 | 10 | 485 | 817 | $369,694 | $64,379 |
Total Patients
1,394
Total Services
2,354
Medicare Billing
$186,036
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 102 | $50,808 | $13,730 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 133 | $50,058 | $8,350 | 16.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 68 | $39,932 | $6,327 | 15.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 28 | $29,747 | $3,854 | 13.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $15,813 | $2,272 | 14.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 43 | 58 | $928.00 | $197.78 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 89 | $41,412 | $12,065 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 102 | $30,311 | $8,333 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 112 | $25,176 | $6,345 | 25.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $18,141 | $4,087 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $5,192 | $1,751 | 33.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 20 | $3,040 | $611.62 | 20.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 55 | 67 | $1,072 | $226.57 | 21.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 78 | 246 | $107,904 | $20,361 | 18.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 88 | 95 | $49,456 | $12,199 | 24.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 61 | 153 | $50,886 | $8,731 | 17.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 36 | $31,223 | $5,526 | 17.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $18,327 | $2,233 | 12.2% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 11 | 26 | $9,698 | $1,740 | 17.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $4,301 | $1,278 | 29.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 42 | $6,966 | $1,231 | 17.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 48 | 60 | $960.00 | $208.80 | 21.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 103 | 288 | $144,583 | $24,279 | 16.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 101 | 222 | $74,492 | $12,721 | 17.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 53 | 55 | $52,699 | $9,050 | 17.2% |
About Dr. Anuja Java, MD
Dr. Anuja Java, MD is a Nephrology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821263559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anuja Java, MD has received a total of $162,504 in payments from pharmaceutical and medical device companies, with $64,231 received in 2024. These payments were reported across 105 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($126,164).
As a Medicare-enrolled provider, Java has provided services to 1,394 Medicare beneficiaries, totaling 2,354 services with total Medicare billing of $186,036. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Saint Louis, MO
- Active Since 04/23/2008
- Last Updated 09/08/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1821263559
Products in Payments
- ULTOMIRIS (Biological) $61,595
- SOLIRIS (Biological) $41,115
- SOLIRIS (Drug) $10,716
- Ultomiris (Drug) $6,625
- TARPEYO (Drug) $325.17
- CABLIVI (Biological) $125.04
- FARXIGA (Drug) $104.88
- LIVTENCITY (Drug) $65.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Saint Louis
Dr. Marcos Rothstein, Md, MD
Nephrology — Payments: $771,005
Nephrology $771,005
Dr. Daniel Coyne, Md, MD
Nephrology — Payments: $322,158
Nephrology $322,158
Dr. Tarek Alhamad, Md, MD
Nephrology — Payments: $237,080
Nephrology $237,080
Krista Lentine, Md,Phd, MD,PHD
Nephrology — Payments: $90,028
Nephrology $90,028
Dr. Tingting Li, Md, MD
Nephrology — Payments: $61,262
Nephrology $61,262
Dr. Thomas Nickolas, Md, MD
Nephrology — Payments: $48,074
Nephrology $48,074